News | Heart Failure | May 16, 2016

New Radar Technology May Reduce Heart Failure Re-Hospitalization

Minneapolis Heart Institute Foundation selected to test product that detects worsening heart failure before patient notices symptoms

May 16, 2016 – To work towards a better method of diagnosis and treatment of congestive heart failure (CHF), Peter Eckman, M.D., with the Minneapolis Heart Institute Foundation (MHIF) is an investigator leading the SMILE (Sensible Medical Innovations Lung fLuid status monitor allows rEducing readmission rate of heart failure patients) study at Abbott Northwestern Hospital, Minneapolis. This study will involve the use of the SensiVest, a product developed by Sensible Medical Innovations, headquartered in Israel. SensiVest is comprised of a wearable vest, with two embedded sensors, and a bedside console.

Patients with CHF are at risk of re-hospitalization when fluid builds up in their lungs. By the time symptoms such as shortness of breath or increased fatigue are present, the fluid build-up often requires medical intervention. This is stressful for the patient, and it’s also costly; the annual cost for CHF treatment in the United States is $30 billion, with half of that going toward hospitalization.

In this study, SensiVest is worn by CHF patients once a day, for a 90-second measurement, to measure the amount of fluid in their lungs. The results are provided to their physician via a secured Web portal. There is no surgery involved, nor does the patient need to visit a clinic or hospital to obtain readings. The physician can review the results and take proactive measures, such as changing medications or dosages, before the patient develops symptoms.

Eckman noted, “Using non-invasive technology to detect fluid buildup in heart failure patients improves our ability to direct treatment before a problem arises, and may reduce risk of re-hospitalization, which is good for the patient and can reduce healthcare costs. We are excited to be part of this type of innovative work.”

A study initially conducted in Israel reported that hospital readmission rates were reduced by 87 percent for patients who were part of the study. Sensible Medical Innovations selected the MHIF as one of 15 sites currently testing the SensiVest in the United States, with plans to expand the study to more hospitals in the future.

Watch a VIDEO showing how the vest works and to hear more about the system.

For more information: www.sensible-medical.com

Related Content

Biotronik Announces U.S. Launch of Edora HF-T QP CRT Pacemaker
Technology | Cardiac Resynchronization Therapy Devices (CRT)| August 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and commercial availability of Edora HF-T QP, an...
Registry Identifies Early Onset of Heart Failure and Lack of Defibrillators in Asia
News | Heart Failure| August 03, 2017
August 3, 2017 — The Asian Pacific Society of Cardiology (ASPC) held its first-ever late-breaking...
Left Atrial Pressure Monitor from Vectorious Medical Technologies Offers New Hope for Heart Failure Patients

On of the top stories in July was the introduction of a left atrial pressure monitor from Vectorious Medical Technologies to prevent heart failure patient hospitalizations or readmissions. Read the article"Left Atrial Pressure Monitor Offers New Hope for Heart Failure Patients."

Feature | August 01, 2017 | Dave Fornell
Aug.
Wearable monitors create patient generated health data, PGHD, that can help prevent acute care episodes in heart failure.

Wearable monitoring devices may offer a new tool to help prevent acute care episodes in heart failure.

Feature | Heart Failure| July 25, 2017 | Lola Koktysh
Despite their best efforts, many patients tend to develop heart failure after an acute event (e.g., a heart attack or
Biotronik Launches DX Technology for U.S. Heart Failure Patients
News | Cardiac Resynchronization Therapy Devices (CRT)| July 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and availability of the Intica DX and Intica...
Hospital Readmissions Analysis Across All Ages, Insurance Types Identifies High-Risk Groups
News | Business| July 20, 2017
July 20, 2017 — Clinician-researchers at Beth Israel Deaconess Medical Center (BIDMC) recently published a first-of-i
Left Atrial Pressure Monitor Offers New Hope for Heart Failure Patients
News | Heart Failure| July 14, 2017
A review appearing in the July 18 issue of the Journal of the American College of Cardiology (JACC) discusses current...
Sponsored Content | Videos | Heart Failure| July 13, 2017
William Abraham, M.D., director of the Division of Cardiovascular Medicine at The Ohio State University Wexner Medica
Overlay Init